MEDICAL DEVICE SYSTEMS FOR PROVIDING IMPEDANCE STATUS

    公开(公告)号:US20240226571A1

    公开(公告)日:2024-07-11

    申请号:US18405230

    申请日:2024-01-05

    发明人: Mitchell A. Tramp

    IPC分类号: A61N1/36 A61N1/02 A61N1/372

    摘要: A system may include a medical device and at least one external device. The medical device may have a plurality of electrodes, and may be configured to measure impedance for each of the plurality of electrodes and generate impedance data. The eternal device(s) may include a display and a processor. The medical device may be configured to communicate the generated impedance data to the at least one eternal device. The processor may be configured to provide on the display a plurality of electrode icons corresponding to the plurality of electrodes, to determine, based on the impedance data, one or more impedance state electrodes from the plurality of electrodes that have an impedance state, and to provide on the display an impedance status representation for one or more of the plurality of electrode icons corresponding to the one or more impedance state electrodes.

    Subcutaneous device for preventing and treating atherosclerosis

    公开(公告)号:US12029897B2

    公开(公告)日:2024-07-09

    申请号:US17240799

    申请日:2021-04-26

    摘要: A subcutaneously implantable device includes a housing and an anchoring mechanism attached to the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue. The device further includes a first prong with a proximal end attached to the housing and a distal end extending away from the housing that is configured to be positioned adjacent to a first blood vessel, and a first electrode on the distal end of the first prong that is configured to be positioned adjacent to the first blood vessel. Circuitry in the housing is in electrical communication with the first electrode that is configured to deliver electrical stimulation using the electrode to create an electric field around the blood vessel.

    IMPLANTABLE NEUROSTIMULATOR
    49.
    发明公开

    公开(公告)号:US20240198117A1

    公开(公告)日:2024-06-20

    申请号:US18554719

    申请日:2022-03-25

    发明人: Tianrui XU

    摘要: An implantable neurostimulator that communicates with an extracorporeal energy controller through radio frequency and receives electrical energy, including: a main control chip that includes a main control CPU, a main memory, and a digital to analog conversion current source circuit; a stimulator antenna and its impedance matching circuit, which are radio-frequency coupled with the extracorporeal energy controller; a rectification energy storage circuit that extracts electrical energy from the received input signal and stores electrical energy; a modulation/demodulation circuit that extracts control information including clinical stimulation parameters from the received input signal; an electrode interface; one or more stimulation electrodes, with the electrode interface allocating stimulation pulse sequences to each corresponding stimulation electrode; wherein the main memory stores the received control information, the digital to analog conversion current source circuit generates the stimulation pulse sequences based on the clinical stimulation parameters, and the main control CPU controls operation of the implantable neurostimulator. The implantable neurostimulator of the present invention can avoid treatment failure caused by interruption or obstruction of radio frequency communication.

    WIRELESS DEEP BRAIN STIMULATION DEVICE
    50.
    发明公开

    公开(公告)号:US20240198113A1

    公开(公告)日:2024-06-20

    申请号:US18556833

    申请日:2022-04-21

    申请人: BIONET SONAR

    IPC分类号: A61N1/372 A61N1/36

    摘要: Systems and methods for wireless deep brain stimulation using ultrasonic waves. Implantable device(s) for intracranial use within a subject may comprise at least one stimulation means, one or more circuits for collecting system data, a receiver, and a transmitter for communications using ultrasonic waves. A wearable controller external to the subject, the wearable controller configured to: communicate with the implantable device(s) using the ultrasonic waves and obtain the system data, analyze the system data to determine whether the subject is experiencing or is expected to experience an adverse medical condition, and communicate with the implantable device(s) using the ultrasonic waves to apply a stimulation to treat the adverse medical condition. The system may be used to treat Parkinson's Disease, for example.